WallStreetZenWallStreetZen

NYSE: NGVT
Ingevity Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NGVT

Based on 1 analyst offering 12 month price targets for Ingevity Corp

Min Forecast
$75.00+5.75%
Avg Forecast
$75.00+5.75%
Max Forecast
$75.00+5.75%

Should I buy or sell NGVT stock?

Based on 1 analyst offering ratings for Ingevity Corp.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NGVT stock forecasts and price targets.

NGVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-27

1 of 1

Forecast return on equity

Is NGVT forecast to generate an efficient return?

Company
573.19%
Industry
33.29%
Market
145.91%
NGVT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NGVT forecast to generate an efficient return on assets?

Company
13.51%
Industry
10.52%
NGVT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NGVT earnings per share forecast

What is NGVT's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$5.03
Avg 2 year Forecast
$5.87
Avg 3 year Forecast
$6.41

NGVT revenue forecast

What is NGVT's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$1.1B-7.45%
Avg 2 year Forecast
$1.1B-9.44%
Avg 3 year Forecast
$1.1B-8.86%
NGVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NGVT revenue growth forecast

How is NGVT forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
-4.4%
Industry
5.7%
Market
16.18%
NGVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NGVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NGVT vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
NGVT$70.92$75.00+5.75%Hold
KWR$143.47$169.75+18.32%Strong Buy
MTX$77.31$90.00+16.41%Strong Buy
WTTR$18.47$22.33+20.91%Strong Buy
OLN$24.20$27.09+11.95%Hold
View Top Specialty Chemical Stocks

Ingevity Stock Forecast FAQ

Is Ingevity Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: NGVT) stock is to Hold NGVT stock.

Out of 1 analyst, 0 (0%) are recommending NGVT as a Strong Buy, 0 (0%) are recommending NGVT as a Buy, 1 (100%) are recommending NGVT as a Hold, 0 (0%) are recommending NGVT as a Sell, and 0 (0%) are recommending NGVT as a Strong Sell.

If you're new to stock investing, here's how to buy Ingevity stock.

What is NGVT's earnings growth forecast for 2026-2028?

(NYSE: NGVT) Ingevity's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 16.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.48%.

Ingevity's earnings in 2026 is -$127,800,000.On average, 6 Wall Street analysts forecast NGVT's earnings for 2026 to be $174,852,920, with the lowest NGVT earnings forecast at $160,158,404, and the highest NGVT earnings forecast at $188,758,119. On average, 6 Wall Street analysts forecast NGVT's earnings for 2027 to be $204,113,297, with the lowest NGVT earnings forecast at $177,196,532, and the highest NGVT earnings forecast at $223,442,880.

In 2028, NGVT is forecast to generate $222,969,985 in earnings, with the lowest earnings forecast at $184,011,783 and the highest earnings forecast at $257,762,538.

What is NGVT's revenue growth forecast for 2026-2028?

(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of -4.4% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.18%.

Ingevity's revenue in 2026 is $1,211,300,000.On average, 6 Wall Street analysts forecast NGVT's revenue for 2026 to be $38,979,064,490, with the lowest NGVT revenue forecast at $36,405,959,430, and the highest NGVT revenue forecast at $40,961,050,820. On average, 6 Wall Street analysts forecast NGVT's revenue for 2027 to be $38,144,543,930, with the lowest NGVT revenue forecast at $31,057,030,357, and the highest NGVT revenue forecast at $42,178,059,970.

In 2028, NGVT is forecast to generate $38,387,945,760 in revenue, with the lowest revenue forecast at $31,915,891,100 and the highest revenue forecast at $42,560,548,560.

What is NGVT's forecast return on assets (ROA) for 2026-2028?

(NYSE: NGVT) forecast ROA is 13.51%, which is higher than the forecast US Specialty Chemicals industry average of 10.52%.

What is NGVT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NGVT price target, the average NGVT price target is $75.00, with the highest NGVT stock price forecast at $75.00 and the lowest NGVT stock price forecast at $75.00.

The Wall Street analyst predicted that Ingevity's share price could reach $75.00 by Feb 27, 2027. The average Ingevity stock price prediction forecasts a potential upside of 5.75% from the current NGVT share price of $70.92.

What is NGVT's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NGVT) Ingevity's current Earnings Per Share (EPS) is -$3.46. On average, analysts forecast that NGVT's EPS will be $5.03 for 2026, with the lowest EPS forecast at $4.61, and the highest EPS forecast at $5.43. On average, analysts forecast that NGVT's EPS will be $5.87 for 2027, with the lowest EPS forecast at $5.10, and the highest EPS forecast at $6.43. In 2028, NGVT's EPS is forecast to hit $6.41 (min: $5.29, max: $7.41).

What is NGVT's forecast return on equity (ROE) for 2026-2028?

(NYSE: NGVT) forecast ROE is 573.19%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.